Flurbiprofen
Flurbiprofen
|
Systematic (IUPAC) name |
---|
(RS)-2-(2-fluorobiphenyl-4-yl)propanoic acid |
Clinical data |
---|
Trade names |
Ansaid, Ocufen, Strepfen |
---|
AHFS/Drugs.com |
monograph |
---|
MedlinePlus |
a687005 |
---|
Pregnancy category |
|
---|
Routes of administration |
Oral |
---|
Legal status |
---|
Legal status |
|
---|
Pharmacokinetic data |
---|
Protein binding |
> 99% |
---|
Metabolism |
Hepatic (CYP2C9) |
---|
Biological half-life |
4.7-5.7 hours |
---|
Excretion |
Renal |
---|
Identifiers |
---|
CAS Number |
5104-49-4 Y |
---|
ATC code |
M01AE09 (WHO) , M02AA19 (WHO), R02AX01 (WHO), S01BC04 (WHO) |
---|
PubChem |
CID 3394 |
---|
IUPHAR/BPS |
4194 |
---|
DrugBank |
DB00712 Y |
---|
ChemSpider |
3277 Y |
---|
UNII |
5GRO578KLP Y |
---|
KEGG |
D00330 Y |
---|
ChEBI |
CHEBI:5130 Y |
---|
ChEMBL |
CHEMBL563 Y |
---|
Synonyms |
(±)-2-fluoro-α-methyl-(1,1'-biphenyl)-4-acetic acid |
---|
PDB ligand ID |
FLP (PDBe, RCSB PDB) |
---|
Chemical data |
---|
Formula |
C15H13FO2 |
---|
Molar mass |
244.261 g/mol |
---|
Chirality |
Racemic mixture |
---|
Fc2cc(ccc2c1ccccc1)C(C(=O)O)C
|
InChI=1S/C15H13FO2/c1-10(15(17)18)12-7-8-13(14(16)9-12)11-5-3-2-4-6-11/h2-10H,1H3,(H,17,18) YKey:SYTBZMRGLBWNTM-UHFFFAOYSA-N Y
|
Physical data |
---|
Melting point |
117 °C (243 °F) |
---|
(verify) |
---|
Flurbiprofen is a member of the phenylalkanoic acid derivative family of non-steroidal anti-inflammatory drugs (NSAIDs). It is primarily indicated as a pre-operative anti-miotic (in an ophthalmic solution) as well as orally for arthritis or dental pain.[1] It is generic and is marketed under brand names worldwide, including "Ansaid" and "Froben".[2]
It was derived from propionic acid by the research arm of Boots UK during the 1960s, a period which also included the discovery of ibuprofen, indometacin, diclofenac, naproxen, ketoprofen, and sulindac.[3][4][5]:34
Side effects are analogous to those of ibuprofen. As of 2015 the cost for a typical month of medication in the United States is 50 to 100 USD.[6]
References
|
---|
| Receptor (ligands) | DP (D2) | | |
---|
| |
- Antagonists: ADC-3680
- AZD-1981
- Bay U3405
- Fevipiprant
- MK-1029
- MK-7246
- OC-459
- OC000459
- QAV-680
- Ramatroban
- Setipiprant
- TM30089
- Vidupiprant
|
---|
|
---|
| EP (E2) | |
- Antagonists: AH-6809
- ONO-8130
- SC-19220
- SC-51089
- SC-51322
|
---|
| |
- Antagonists: AH-6809
- PF-04418948
- TG 4-155
|
---|
| | |
---|
| |
- Antagonists: GW-627368
- L-161982
- ONO-AE3-208
|
---|
| Unsorted | |
---|
|
---|
| FP (F2α) | |
---|
| IP (I2) | |
---|
| TP (TXA2) | |
---|
| Unsorted |
- Arbaprostil
- Ataprost
- Ciprostene
- Clinprost
- Cobiprostone
- Delprostenate
- Deprostil
- Dimoxaprost
- Doxaprost
- Ecraprost
- Eganoprost
- Enisoprost
- Eptaloprost
- Esuberaprost
- Etiproston
- Fenprostalene
- Flunoprost
- Froxiprost
- Lanproston
- Limaprost
- Luprostiol
- Meteneprost
- Mexiprostil
- Naxaprostene
- Nileprost
- Nocloprost
- Ornoprostil
- Oxoprostol
- Penprostene
- Pimilprost
- Piriprost
- Posaraprost
- Prostalene
- Rioprostil
- Rivenprost
- Rosaprostol
- Spiriprostil
- Tiaprost
- Tilsuprost
- Tiprostanide
- Trimoprostil
- Viprostol
|
---|
|
---|
| Enzyme (inhibitors) | |
---|
| Others | |
---|
| See also: Leukotrienergics |
|